Skip to main content

Genetic Diversity Analysis

Nutritional quality evaluation and genetic diversity analysis of walnut nuts


Walnut (Juglans regia L.) trees have been seed-propagated for over a thousand years in Tibet, thriving under variable climatic conditions at altitudes exceeding 3,000 m. This study conducted a comprehensive evaluation of the nutritional quality of 175 walnuts, identifying the highest-performing accessions. Additionally, 20 simple sequence repeat (SSR) loci were employed to assess the extent of genetic diversity and the genetic relationships among the walnuts. The walnut JC174, JC170, and JC126 were ranked among the top three based on a comprehensive evaluation using principal component analysis.

A total of 319 alleles were identified, and seven highly polymorphic loci, including SSR6, were selected for further study. The genetic diversity analysis indicated that the majority of genetic variation in Jiacha walnuts was observed among individuals, leading to the division of the population into two distinct groups. This study provides valuable theoretical insights and practical foundations for the advancement of the walnut industry in the Tibetan region.

The coefficient of variation among walnut monocultures in Jiacha County was found to be significant. Based on the comprehensive evaluation of the nutritional quality of Jiacha walnuts, the top three walnut trees were identified as JC174, JC170, and JC126, respectively. Jiacha walnuts can be broadly categorized into three types: nutritious fruits, fresh fruits, and balanced fruits. Furthermore, seven highly polymorphic loci were identified, and Jiacha walnuts were divided into two distinct taxa. This analysis clarified that the genetic variation in Jiacha walnuts primarily exists among individuals, with the YJN group exhibiting the highest degree of genetic differentiation. These findings provide the genetic foundation for the selection of breeding materials in future breeding programs.

Genetics, heredity, DNA, genes, genome, mutation, chromosomal disorders, genetic variation, gene expression, genetic engineering, molecular biology, genomics, epigenetics, inherited traits, genetic testing, personalized medicine, population genetics, genetic disorders, gene therapy, biotechnology

#Genetics, #DNA, #Genes, #Genomics, #GeneticResearch, #MolecularBiology, #Epigenetics, #GeneTherapy, #GeneticDisorders, #GeneticEngineering, #Biotechnology, #Heredity, #Genome, #PersonalizedMedicine, #GeneticTesting, #InheritedTraits, #ChromosomalDisorders, #Mutation, #GeneticVariation, #PopulationGenetics

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: support@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare
linkedin.com/in/genetics-research-160337363

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
Post a Comment
Read more